Clinical Trials Browser

Unknown × temsirolimus × Gastrointestinal × Clear all

NCT01567930 2012-12-17

Temsirolimus as Second-line Therapy in HCC

Phase 2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular